1. A comparative study of two regimens of combination chemotherapy in acute leukemia;Frei;Blood,1958
2. Note for guidance III/3630/92-EN, biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products;Stat. Med.,1995
3. Committee for Proprietary Medicinal Products (CPMP). Points to Consider on Switching Between Superiority and Non-Inferiority. CPMP/EWP/482/99, 2000.
4. European Agency for the Evaluation of Medicinal Products. Concept Paper on the Development of a Committee for Proprietary Medicinal Products (CPMP). Points to Consider on Biostatistical/Methodological Issues Arising from Recent CPMP Discussions on Licensing Applications: Choice of Delta. CPMP/EWP/2158/99, 1999.
5. European Agency for the Evaluation of Medicinal Products. Concept Paper on the Development of a Committee for Proprietary Medicinal Products (CPMP). Points to Consider on Biostatistical/Methodological Issues Arising from Recent CPMP Discussions on Licensing Applications: Adjustment for Multiplicity and Related Topics. CPMP/EWP/908/99, 1999.